Specialty drugs get more expensive

Wall Street Journal Health Blog, September 26, 2008
Specialty drugs—often sold by biotech companies, and used to treat complex conditions such as cancer—are some of the most expensive medicines on the market, and their prices are rising much faster than inflation, and even faster than the prices of other prescription drugs. Last year, the wholesale price of specialty drugs rose 8.7%, three times the rate of inflation, while non-specialty, branded drugs rose 7.4%, and the price of generic drugs fell by 9.6%.

MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.